SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Ionis Pharmaceuticals (IONS)
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
4676 121 0 IONS
Emcee:  Keith Fauci Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
4426very involved with PIPE and other second level financings including the diffucltbob zagorin-4/18/2008
4425I had never heard of leerink until the post. Here is their website. leerink.coMJ-4/18/2008
4424huh? Downgrades Company Ticker Brokerage Firm Ratings Change Price Target bob zagorin-4/18/2008
4423Isis Reports Reduction of apoB-100 Levels in a Murine Model Resulting in Up to 9bob zagorin-4/18/2008
4422more.. "...WACHOVIA: "Has the Tide Turned?" Has the Tide Turned bob zagorin-4/18/2008
4421from IV thread.. "...A quick note from Wachovia about "participation bob zagorin-4/18/2008
4420GlaxoSmithKline and Regulus Therapeutics Form Strategic Alliance To Develop Micrbob zagorin-4/17/2008
4419Regulus Therapeutics to Host Conference Call to Discuss GlaxoSmithKline Alliancebob zagorin-4/17/2008
4418wachovia update on isis interim safety results..(repost from iv) ISIS: Mipomersbob zagorin-4/15/2008
4417good summary of the conf. call from the iv board "...very bullish CC 1. SCbob zagorin-4/15/2008
4416 Print this Page for Your Records Close Window Presentation Time: 4/17/2008 5bob zagorin-4/14/2008
4415ISIS PHARMACEUTICALS, INC. AT THE AMERICAN ASSOCIATION FOR CANCER RESEARCH’S ANNbob zagorin-4/14/2008
4414Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Ibob zagorin-4/14/2008
4413shorts 25% of float as of 3/31 shortsqueeze.combob zagorin-4/9/2008
4412Isis Ignited by Bristol-Myers fool.com Brian Orelli April 9, 2008 Isis may bebob zagorin-4/9/2008
4411Bristol-Myers Squibb Selects Isis Drug Targeting Pcsk9 as Development Candidate bob zagorin-4/8/2008
4410iae, the balance sheet improvements are very significant imo.. at least $500m mabob zagorin-4/7/2008
4409I've owned ISIS for many years and believe the views in the IBD article are Art Bechhoefer-4/7/2008
4408<b><i><big flashing letters>"I would avoid suggesting anyDr. Voodoo-4/5/2008
4407IBD article investors.com Biotech Has Friends In High Places BY PETER BENESH INbob zagorin-4/5/2008
4406Vytorin Miss Could Open Wider Window for Others By Jennifer Boggs Assistant Mabob zagorin-4/5/2008
4405Some Drug Makers See Rare Diseases As Step To Bigger Markets Dow Jones April 04,bob zagorin-4/4/2008
4404Biotech pioneer offers insights and favorites Friday, 04 April 2008 I'm a lbob zagorin-4/4/2008
4403Dr. John Kastelein was (and may still be) one of the lead investigators on the Ibob zagorin-4/1/2008
4402here is an isis news release from october reporting p2 results on mipomersen andbob zagorin-3/31/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News